Crossmark

Left atrial appendage closure: Current status, unresolved issues, and future perspectives

Published Online: 2025-12-11

Published Print: 2026-04

Authors

Kondo, Yusuke https://orcid.org/0000-0003-4985-6929
Ryuzaki, Satoko

Nakano, Miyo

Kobayashi, Yoshio
License Information

Text and Data Mining valid from 2025-12-11

Version of Record valid from 2025-12-11
More Information

Article History

Received: 11 November 2025

Accepted: 12 November 2025

First Online: 11 December 2025

Declaration

:

: This study did not receive any specific funding. Dr. Kondo received lecture fees from Daiichi-Sankyo, Bayer, Abbott Medical Japan, Biotronik Japan, Boston Scientific, Japan Lifeline, Medtronic, and research funds from Daiichi-Sankyo and Boston Scientific. Dr. Ryuzaki belongs to the endowed department from Medtronic Japan. Dr. Nakano belongs to the endowed department from Abbott Medical Japan, Biotronik Japan and Fukuda Denshi. Dr. Kobayashi received lecture fees from Abbott Medical Japan, Bayer Japan, Bristol-Myers Squibb, Boehringer Ingelheim, and Daiichi-Sankyo, and scholarship funds from Takeda Pharmaceutical, Abbott Medical Japan, Terumo, Otsuka Pharmaceutical, Boehringer Ingelheim, Astellas, Daiichi-Sankyo, Win International, Japan Lifeline, and Nipro. Dr. Kobayashi is the Editor-in-Chief of Cardiovascular Intervention and Therapeutics.

Document is current